Position
VAN ECK ASSOCIATES CORP in Beam Therapeutics Inc.
Back to the book · All holders of BEAM
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$11$0.03 → $0.02
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 3.92K | $109 | — | — | — | 0.0% |
| Q1 2026 | 2.88K | $69 | $0.02 | −$11 | −$29 | 0.0% |